rs560596101

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_007194.4(CHEK2):c.444+2T>G variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000657 in 152,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)

Consequence

CHEK2
NM_007194.4 splice_donor, intron

Scores

Splicing: ADA: 0.9993

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 7.10

Publications

3 publications found

Variant links:

Genes affected

CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

CHEK2 Gene-Disease associations (from GenCC):

CHEK2-related cancer predisposition
Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
hereditary breast carcinoma
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
Li-Fraumeni syndrome 2
Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
acute myeloid leukemia
Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
hereditary nonpolyposis colon cancer
Inheritance: AD Classification: LIMITED Submitted by: ClinGen
familial ovarian cancer
Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

CHEK2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1

Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 8.7, offset of 4, new splice context is: gagGTaatg. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.

PM2

Very rare variant in population databases, with high coverage;

PP5

Variant 22-28725241-A-C is Pathogenic according to our data. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725241-A-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 2584223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CHEK2	NM_007194.4 link	c.444+2T>G		splice_donor_variant, intron_variant	Intron 3 of 14	ENST00000404276.6	NP_009125.1	O96017-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CHEK2	ENST00000404276.6 link	c.444+2T>G		splice_donor_variant, intron_variant	Intron 3 of 14	1	NM_007194.4	ENSP00000385747.1		O96017-1

Frequencies

GnomAD3 genomes

AF:

0.00000657

AC:

AN:

152170

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.0000655

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.00000398

AC:

AN:

251280

AF XY:

0.00000736

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.0000289

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

Cov.:

GnomAD4 genome

AF:

0.00000657

AC:

AN:

152288

Hom.:

Cov.:

AF XY:

0.0000134

AC XY:

AN XY:

74454

show subpopulations

⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.

African (AFR)

AF:

0.00

AC:

AN:

41582

American (AMR)

AF:

0.0000655

AC:

AN:

15276

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3466

East Asian (EAS)

AF:

0.00

AC:

AN:

5186

South Asian (SAS)

AF:

0.00

AC:

AN:

4826

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10610

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68022

Other (OTH)

AF:

0.00

AC:

AN:

2114

⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.375

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

ExAC

AF:

0.00000824

AC:

ClinVar

Significance: Pathogenic/Likely pathogenic

Submissions summary: Pathogenic:2

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Familial cancer of breast

Pathogenic:2

Dec 16, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This sequence change affects a donor splice site in intron 3 of the CHEK2 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (rs560596101, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2584223). Studies have shown that disruption of this splice site results in activation of cryptic splice sites, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 26506619; internal data). For these reasons, this variant has been classified as Pathogenic. -

Jun 23, 2023

Myriad Genetics, Inc.

Significance:Likely pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_addAF

Benign

-0.019

BayesDel_noAF

Benign

-0.18

CADD

Pathogenic

(source)

DANN

Benign

0.80

Eigen

Pathogenic

0.68

Eigen_PC

Uncertain

0.50

FATHMM_MKL

Uncertain

0.95

PhyloP100

7.1

GERP RS

4.8

Mutation Taster

=1/99

disease causing

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

dbscSNV1_ADA

Pathogenic

1.0

dbscSNV1_RF

Benign

0.59

SpliceAI score (max)

1.0

Details are displayed if max score is > 0.2

DS_DG_spliceai

0.93

Position offset: -2

DS_DL_spliceai

1.0

Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over